Diabetes drug shows promise for PCOS in new study
NCT ID NCT05966792
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at whether a type of diabetes drug called SGLT2 inhibitors can help women with Polycystic Ovary Syndrome (PCOS) better than the standard drug metformin. The researchers believe these drugs may work by reducing inflammation in the body. The study involved 82 women aged 18-45 with PCOS and a BMI of 20 or higher, and measured changes in menstrual cycles and markers of inflammation.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POLYCYSTIC OVARY SYNDROME are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Shanghai Tenth People'S Hospital
Shanghai, Shanghai Municipality, 200072, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a Weight-Loss drug tame PCOS hormones?
- Could interval training and fasting tame PCOS insulin resistance?
- New PCOS study aims to map hidden patterns of the condition
- New hope for PCOS: extended letrozole or adding inositol may help ovulation
- New hope for PCOS: supplement combo aims to restore ovulation
- Could a protein boost make a PCOS supplement work better?